Results 41 to 50 of about 15,278 (221)

Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication

Globalization and Health, 2020
The World Health Organisation Western Pacific Region countries were declared free of polio in 2000 until a polio outbreak involving 305 cases occurred in Indonesia in 2006.
Long Chiau Ming, Zahid Hussain, Siang Fei Yeoh, David Koh, Kah Seng Lee   +4 more
doaj   +1 more source

Multiscale model for forecasting Sabin 2 vaccine virus household and community transmission.

PLoS Computational Biology, 2021
Since the global withdrawal of Sabin 2 oral poliovirus vaccine (OPV) from routine immunization, the Global Polio Eradication Initiative (GPEI) has reported multiple circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks.
Michael Famulare, Wesley Wong, Rashidul Haque, James A Platts-Mills, Parimalendu Saha, Asma B Aziz, Tahmina Ahmed, Md Ohedul Islam, Md Jashim Uddin, Ananda S Bandyopadhyay, Mohammed Yunus, Khalequ Zaman, Mami Taniuchi   +12 more
doaj   +1 more source

From regional pulse vaccination to global disease eradication: insights from a mathematical model of Poliomyelitis [PDF]

, 2014
Mass-vaccination campaigns are an important strategy in the global fight against poliomyelitis and measles. The large-scale logistics required for these mass immunisation campaigns magnifies the need for research into the effectiveness and optimal ...
AJ Terry, AL Lloyd, B Alyward, B Shulgin, Cameron J. Browne, CC Chicone, CJ Browne, DD Bainov, DD Bainov, DD Bainov, DJD Earn, DM Morens, HR Thieme, J Burton, J Liu, JM Heffernan, KR Yameogo, L Bourouiba, LS Liebovitch, Lydia Bourouiba, M Kirkilionis, ME Birmingham, N Bacaer, N Bacaer, N Bacaër, P Driessche van den, PEM Fine, R Breban, Robert J. Smith, S Zipursky, V Lakshmikantham, W Wang, X Meng, X-Q Zhao, Y Xiao, YP Yang, Z Agur   +36 more
core   +2 more sources

Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents

Advanced Functional Materials, Volume 36, Issue 26, 30 March 2026.
Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras, Imelda Raczkiewicz, Peggy Bouquet, Jean‐Philippe Dacquin, Jeremy Dhainaut, Anne Goffard, Christophe Volkringer   +6 more
wiley   +1 more source

Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014. [PDF]

, 2014
In August 2012, the California Department of Public Health (CDPH) was contacted by a San Francisco Bay area clinician who requested poliovirus testing for an unvaccinated man aged 29 years with acute flaccid paralysis (AFP) associated with anterior ...
Ayscue, Patrick, Centers for Disease Control and Prevention (CDC), Clayton, Anna, Feikin, Daniel, Glaser, Carol, Harriman, Kathleen, Nix, William Allan, Padilla, Tasha, Pan, Chao, Reichel, John, Sejvar, James, Sheriff, Heather, Van Haren, Keith, Waldron, Paul, Watt, James, Waubant, Emmanuelle, Yagi, Shigeo, Yen, Cynthia   +17 more
core   +1 more source

Epidemiological Characteristics of Poliomyelitis During the 21st Century (2000-2013) [PDF]

, 2014
Poliovirus is the pathogenic agent of paralytic poliomyelitis that belongs to the picornaviridae family. Poliomyelitis has an extended history dating over to the Egyptian eighteenth dynasty.
Ahmad, T. (Tahir), Anjum, S. (Sadia), Arif, S. (Sania), Chaudry, N. (Nazia)   +3 more
core   +1 more source

Bee products as alternatives in the treatment of viral infections

Journal of the Science of Food and Agriculture, Volume 106, Issue 1, Page 33-54, 15 January 2026.
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba, Łukasz Marek, Jerzy Stojko, Anna Rzepecka‐Stojko   +3 more
wiley   +1 more source

Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

Emerging Infectious Diseases
Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine.
Farrell A. Tobolowsky, Fred Nsubuga, Zunera Gilani, Annet Kisakye, Helen Ndagije, Daniel Kyabayinze, Jane F. Gidudu   +6 more
doaj   +1 more source

Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan

Vaccines, 2023
The oral poliovirus vaccine (OPV) has been the mainstay of polio eradication, especially in low-income countries, and its use has eliminated wild poliovirus type 2.
Muhammad Atif Habib, Sajid Bashir Soofi, Imtiaz Hussain, Imran Ahmed, Zamir Hussain, Rehman Tahir, Saeed Anwar, Simon Cousens, Zulfiqar A. Bhutta   +8 more
doaj   +1 more source

Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data. [PDF]

, 2016
BACKGROUND: Global withdrawal of serotype-2 oral poliovirus vaccine (OPV2) took place in April 2016. This marked a milestone in global polio eradication and was a public health intervention of unprecedented scale, affecting 155 countries.
Blake, Isobel M, Etsano, Andrew, Grassly, Nicholas C, Jafari, Hamid, Molodecky, Natalie A, O'Reilly, Kathleen M, Pons-Salort, Margarita, Safdar, Rana M, Vaz, Rui Gama, Wadood, Mufti Zubair   +9 more
core   +4 more sources